» Articles » PMID: 17991290

High-fat Diet Modulates Non-CD1d-restricted Natural Killer T Cells and Regulatory T Cells in Mouse Colon and Exacerbates Experimental Colitis

Overview
Date 2007 Nov 10
PMID 17991290
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Environmental factors such as diet are known to play important roles in inflammatory bowel disease (IBD). Epidemiological studies have indicated that a high-fat diet is a risk factor for IBD. In addition, the balance between effector T cells (T(eff)) and regulatory T cells (T(reg)) contributes to the pathogenesis of mucosal inflammation. The aim of this study was to understand the mechanisms by which a high-fat diet can regulate susceptibility to intestinal inflammation. Wild-type C57BL/6 mice were fed either a commercial high-fat diet or a normal diet, then exposed to dextran sulphate sodium (DSS) to induce colonic inflammation. Intraepithelial lymphocytes (IEL) were isolated from the colon, and their phenotype and cytokine profile were analysed by flow cytometry. Mice receiving the high-fat diet were more susceptible to DSS-induced colitis. They had higher numbers of non-CD1d-restricted natural killer (NK) T cells in the colonic IEL, when compared to mice fed a normal diet. These cells expressed tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma, which are up-regulated by high-fat diets. Mice fed the high-fat diet also had decreased levels of colonic T(reg). Depletion of colonic NK T cells or adoptive transfer of T(reg) reduced the DSS colitis in these mice, and reduced the colonic expression of TNF-alpha and IFN-gamma. We conclude that a high-fat diet can increase non-CD1d-restricted NK T cells and decrease T(reg) in the colonic IEL population. This altered colonic IEL population leads to increased susceptibility to DSS-induced colitis. This effect may help to explain how environmental factors can increase the susceptibility to IBD.

Citing Articles

Experimental colonization with H. hepaticus, S. aureus and R. pneumotropicus does not influence the metabolic response to high-fat diet or incretin-analogues in wildtype SOPF mice.

Wunderlich M, Miller M, Ritter B, Le Gleut R, Marchi H, Majzoub-Altweck M Mol Metab. 2024; 87:101992.

PMID: 39019114 PMC: 11338133. DOI: 10.1016/j.molmet.2024.101992.


New insights into the mechanisms of high-fat diet mediated gut microbiota in chronic diseases.

Chen J, Xiao Y, Li D, Zhang S, Wu Y, Zhang Q Imeta. 2024; 2(1):e69.

PMID: 38868334 PMC: 10989969. DOI: 10.1002/imt2.69.


Insights Into Inflammatory Bowel Disease and Effects of Dietary Fatty Acid Intake With a Focus on Polyunsaturated Fatty Acids Using Preclinical Models.

Smyth M, Lunken G, Jacobson K J Can Assoc Gastroenterol. 2024; 7(1):104-114.

PMID: 38314173 PMC: 10837003. DOI: 10.1093/jcag/gwad058.


Role of CD1d and iNKT cells in regulating intestinal inflammation.

Lee S, Park H, Van Kaer L, Hong S Front Immunol. 2024; 14:1343718.

PMID: 38274786 PMC: 10808723. DOI: 10.3389/fimmu.2023.1343718.


The Effects of a High-Fat Diet on Inflammatory Bowel Disease.

Dang Y, Ma C, Chen K, Chen Y, Jiang M, Hu K Biomolecules. 2023; 13(6).

PMID: 37371485 PMC: 10296751. DOI: 10.3390/biom13060905.


References
1.
Grimble R . Nutritional modulation of immune function. Proc Nutr Soc. 2001; 60(3):389-97. DOI: 10.1079/pns2001102. View

2.
Klugewitz K, Adams D, Emoto M, Eulenburg K, Hamann A . The composition of intrahepatic lymphocytes: shaped by selective recruitment?. Trends Immunol. 2004; 25(11):590-4. DOI: 10.1016/j.it.2004.09.006. View

3.
Li Z, Soloski M, Diehl A . Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology. 2005; 42(4):880-5. DOI: 10.1002/hep.20826. View

4.
Endres S, Ghorbani R, Kelley V, Georgilis K, Lonnemann G, van der Meer J . The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 1989; 320(5):265-71. DOI: 10.1056/NEJM198902023200501. View

5.
Lantz O, Bendelac A . An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J Exp Med. 1994; 180(3):1097-106. PMC: 2191643. DOI: 10.1084/jem.180.3.1097. View